Skip to main content
Clinical Trials/NCT02783287
NCT02783287
Completed
Not Applicable

The Impact of Text Messaging on Medication Adherence and Exercise Regimen Among Post-myocardial Infarction Patients

Brigham and Women's Hospital0 sites84 target enrollmentJanuary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Myocardial Infarction
Sponsor
Brigham and Women's Hospital
Enrollment
84
Primary Endpoint
Medication adherence
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to assess the impact of text message reminders on adherence to medications and exercise in patients recently discharged from the hospital after a myocardial infarction (MI).

Detailed Description

The Impact of Text Messaging on Medication Adherence and Exercise Regimen among Post-Myocardial Infarction Patients includes two single-center randomized control trials to assess the impact of text message reminds on adherence to medications and exercise regimen in patients recently discharged from the hospital after MI. Recruitment conducted at Cambridge Cardiac Rehabilitation in Ontario, Canada for both the medication adherence and exercise trial. Potential study subjects are evaluated for inclusion and exclusion criteria, give written informed consent, and are randomized, in a 1:1 ratio, to either intervention or usual care (control). Patients randomized to the intervention arm in the medication adherence trial receive an automated text message once per day at the time they are prescribed to take their medication. The text message does not contain any personal or pharmacological information. Patients randomized to the intervention arm in the exercise adherence trial receive four text messages per day at 7:30 am, 12:00 pm, 6:00 pm, and 9:00 pm, reminding them to exercise for 30 minutes per day as per their health care provider.

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
December 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Niteesh K. Choudhry, MD, PhD

Associate Professor of Medicine at Harvard Medical School, Associate Physician in the Division of Pharmacoepidemiology and Pharmacoeconomics and the Hospitalist Program at Brigham and Women's Hospital

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • Post-MI hospital discharge within 2 weeks
  • Enrolled in cardiac rehabilitation
  • Prescribed anti-platelets, beta-blockers, ACE-inhibitors or ARBs, and/or statins on 1x/day regimen (for medication adherence trial)
  • Prescribed exercise regimen (for exercise trial)
  • Ability to read and write English
  • Possession of a cell phone with text messaging capability

Exclusion Criteria

  • Age \< 18
  • Incarcerated individuals
  • Unable to read and write English
  • Not in possession of a cell phone
  • Patients prescribed medication regimen \> 1x/day

Outcomes

Primary Outcomes

Medication adherence

Time Frame: 12 months

Average medication adherence over 12 months after randomization, assessed with self-reported logs

Exercise frequency

Time Frame: 12 months

Average frequency of exercise over 12 months after randomization, assessed with self-reported logs

Secondary Outcomes

  • Exercise duration(12 months)
  • Full medication adherence(12 months)

Similar Trials